A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal Dementia
PHASE2CompletedINTERVENTIONAL
Enrollment
41
Participants
Timeline
Start Date
May 31, 2003
Study Completion Date
July 31, 2004
Conditions
Frontotemporal DementiaPick Complex
Interventions
DRUG
galantamine hydrobromide
All Listed Sponsors
lead
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY
NCT00416169 - A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal Dementia | Biotech Hunter | Biotech Hunter